For more information or confidential assistance
800-306-3180
se habla español

Jury Awards $15 Million in Depakote Birth Defects Case

A Minnesota family filed a Depakote lawsuit against drugmaker Abbott, alleging that the defendants failed to properly communicate the serious risks of using the drug during pregnancy – which is similar to claims made in lawsuits filed with regard to the dangers of Zofran use during pregnancy. The child, a 12-year-old... Read more »

Two Women File Zofran Lawsuits Alleging Birth Defects

Two women have each filed a Zofran birth defects lawsuit, alleging their children experienced serious defects after the women took the drug to treat morning sickness during their pregnancies. The two lawsuits, filed in Texas and Massachusetts courts, accuse Zofran manufacturer GlaxoSmithKline of failing to reveal risks associated with the drug,... Read more »

Alabama Mother Files Zofran Lawsuit

Premises liability lawyer Los Angeles
An Alabama mother and her nine-year-old son have filed a Zofran lawsuit. The mother’s doctor ordered her to begin taking the drug while she was pregnant, in January 2006, to combat nausea. The baby was born on August 12, 2006 and shortly after, doctors discovered he had a high, narrow... Read more »

Zofran Lawsuit Filed in Montana District Court

In a recent complaint against Zofran manufacturer GlaxoSmithKline (GSK), two Montana parents have alleged significant failures by GSK to properly warn women of the allegedly known risks of congenital birth defects in babies exposed to the drug in utero. The complaint includes the full history of the testing and approval of... Read more »

Minnesota Mother Files Zofran Lawsuit Over Birth Defects

A mother of two young children has filed a Zofran lawsuit against GlaxoSmithKline (GSK) alleging that the anti-nausea medication led to both of her children’s serious health problems. The Minnesota mother filed her lawsuit on behalf of herself and her minor children in the U.S. District Court for the Eastern... Read more »

New Study Explores Transplacental Transfer of Zofran

A recent study published in the medical journal Clinical Pharmacology & Therapeutics evaluated the possibility that the anti-nausea drug, Zofran (ondansetron) might be used to treat neonatal abstinence syndrome. In doing so, the researchers also assessed the possible transfer of the drug from mother to fetus via the placenta. Zofran... Read more »